JPMorgan Chase & Co. (JPM), the largest U.S. bank by assets and market capitalization, has spent late 2026 trading roughly 8% below its 52-week high of $366.50. With shares near $337, investors are asking whether the stock can climb to $380 — a level that would require a breakout to record highs. The answer depends less on a single catalyst than on how the bank's net interest income, credit costs, and capital-markets activity evolve over the coming quarters.
Roughly 15 current, individually attributable price targets were reviewed. They span from a low of $305 (JLPascual, which downgraded the stock to Sell) to a high of $425 (Barclays, Overweight). The arithmetic mean of all these targets is about $369 — only about 9% above the latest price. Because that overall mean sits below the 10% threshold that would make it a meaningful forward objective, the central target here is instead calculated as the average of the targets above the current price, which works out to roughly $379 and is rounded to $380.
Views are split rather than uniform. The most bullish names — Barclays at $425, BofA Securities at $400, UBS at $395, and Wells Fargo at $390 — emphasize scale, earnings durability, and a premium multiple. A broad middle cluster, including Morgan Stanley, HSBC, RBC Capital, TD Cowen, and Evercore ISI, sits between roughly $361 and $377. The cautious end, including Citigroup at $350 and Baird at $312, focuses on valuation and near-term capital-markets softness. These differences are not random; they reflect genuine disagreement about how much of a premium the franchise deserves.
The latest verified price is about $337, giving JPM a market value near $895 billion and a trailing P/E (price-to-earnings ratio) of about 14x. Reaching $380 would require an upside of roughly 13%, a substantial move for a mega-cap bank that has already more than tripled over the past three years. The shares trade on about 13x forward earnings, a premium to the roughly 11x multiple of the broader U.S. banking group — a premium bulls argue is earned, and skeptics argue leaves less margin for error.
The fundamental case rests on durability. Third-quarter revenue grew year over year across Consumer & Community Banking, the Commercial & Investment Bank, and Asset & Wealth Management. Management's preliminary 2027 net interest income (NII) outlook came in above consensus, implying roughly $117 billion — up about 10% — driven by balance-sheet expansion rather than a simple bet on interest rates. BofA Securities' Ebrahim Poonawala, who rates the stock a Buy with a $400 target, also points to roughly $1.5 trillion of cash and securities plus excess capital as a defensive buffer. A return on equity near 18% and a dividend yield near 2% round out the support case.
The obstacles are equally concrete. JPM posted a rare profit miss in the third quarter, with EPS (earnings per share) of about $5.75 versus a roughly $5.94 consensus, as dealmaking and bond trading lost momentum. Credit quality is an open question: CEO Jamie Dimon has publicly cautioned on credit conditions, and reserves and provisioning remain areas to watch. Finally, the valuation premium means multiple compression — rather than any fundamental breakdown — could keep the stock below $380 even if earnings meet expectations.
The chart frames the challenge. The 52-week range runs from $279.10 to $366.50, and the $366.50 level now acts as major resistance — the stock must break decisively above its prior high for $380 to become reachable. Below the current price, the $330 area and the psychological $350 mark are near-term reference points. Because $380 sits above the established range, it represents a technical breakout target as much as a valuation one.
Analyst price targets generally reflect a research horizon of roughly 12 months, though individual firms differ in their assumptions about rates and credit. The next quarterly report is scheduled for January 2027. Investors should watch NII and margin trends, credit-loss provisions, trading and investment-banking revenue, management's updated expense and capital commentary, and any FOMC (Federal Open Market Committee) rate decisions that could reshape deposit costs and lending yields. Upgrades, downgrades, and target revisions from the firms above will also signal how the $380 objective is holding up.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Rather than relying on a single metric, the system scans for shifting trends so traders can discover opportunities, monitor existing positions, and spot reversals more efficiently. For investors tracking a large-cap name like JPM, such tools can complement traditional research by flagging momentum changes earlier than manual review might. Consider exploring the AI Daily Buy/Sell Signals to see how automated signals fit into your own process.
Can JPMorgan Chase reach $380? The target — the average of analyst price targets above the current price — implies a substantial gain of about 13% and would take the stock above its prior record high. The supporting case is strong: diversified revenue growth, above-consensus 2027 NII guidance, and a balance sheet with exceptional loss-absorbing capacity. The counter-case is just as real: a rare earnings miss, a valuation premium versus peers, and lingering credit uncertainty. With targets spanning $305 to $425, the Street itself is divided. Reaching $380 is not a matter of certainty but of whether the bank's earnings durability and premium valuation both hold into 2027 — a question that the January earnings report, credit trends, and rate decisions will help answer.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, JPM has been closely correlated with BAC. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if JPM jumps, then BAC could also see price increases.